<DOC>
	<DOCNO>NCT00683332</DOCNO>
	<brief_summary>The purpose study collect post-marketing information safety Tygacil Filipino patient .</brief_summary>
	<brief_title>Post-Marketing Study Of The Safety Of Tygacil ( Tigecycline )</brief_title>
	<detailed_description>Three-thousand 10 % total number patient give tigecycline include study</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>All patient study center receive receive least one dose Tygacil accord approve product indication . Previously discontinue Tygacil therapy due significant safety concern .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Observational study</keyword>
	<keyword>Tigecycline</keyword>
	<keyword>infection</keyword>
	<keyword>skin</keyword>
	<keyword>abdominal</keyword>
</DOC>